Mirum Pharmaceuticals' stock price targets increased by various analysts.
Mirum Pharmaceuticals (NASDAQ:MIRM) has experienced multiple price target increases by different analysts. Citigroup raised its price target from $38.00 to $64.00, Morgan Stanley from $53.00 to $57.00, JPMorgan Chase & Co. from $31.00 to $39.00, and HC Wainwright from $58.00 to $66.00. Most analysts maintain a buy or overweight rating on the stock.
June 22, 2024
3 Articles